Alex J. Spurling
Melbourne, VIC 3086, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
A switch in mechanism of action prevents doxorubicin-mediated cardiac damage.
Journal: Biochemical pharmacology
Published: October 22, 2020
Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 10, 2020
Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancer.
Journal: Clinical & translational immunology
Published: June 14, 2020
Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis.
Journal: Nature communications
Published: July 26, 2019
Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice.
Journal: BMC cancer
Published: March 22, 2019
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.
Journal: NPJ precision oncology
Published: December 07, 2018
Colorimetric histology using plasmonically active microscope slides.
Journal: Nature
Published: November 03, 2017
Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
Journal: The Journal of pathology
Published: July 04, 2017
Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC.
Journal: Cancer immunology research
Published: March 27, 2017
Encapsulation of Mitoxantrone within Cucurbit[8]uril Decreases Toxicity and Enhances Survival in a Mouse Model of Cancer.
Journal: ACS medicinal chemistry letters
Published: March 01, 2017
Last Updated: 09/26/2026